Hepatitis C virus (HCV) core protein has been shown to interact with the death domain (DD) of tumor necrosis factor receptor-1 (TNFR1). In this study, we further examined the interaction of the core protein with the signaling molecules of TNFR1, including FADD, TRADD, and TRAF2, in a human embryonic kidney cell line, HEK-293, that overexpresses the HCV core protein. This core protein-expressing cell line exhibited enhanced sensitivity to TNF-induced apoptosis. By in vitro binding and in vivo coimmunoprecipitation assays, we showed that the HCV core protein interacted with the DD of FADD and enhanced apoptosis induced by FADD overexpression. This enhancement could be blocked by a dominant-negative mutant of FADD. In contrast, the core protein did not directly interact with the DD of TRADD, but could disrupt the binding of TRADD to TNFR1. TRAF2 recruitment to the TNFR1 signaling complex was also disrupted by the core protein. Correspondingly, TRAF2-dependent activation of the protein kinase JNK was suppressed in the core protein-expressing cells. However, NFB activation by TNF was not significantly altered by the HCV core protein, suggesting the existence of TRAF2-independent pathways for NFB activation. These results combined indicate that the HCV core protein sensitizes cells to TNF-induced apoptosis primarily by facilitating FADD recruitment to TNFR1. The inhibition of JNK activation by the HCV core protein may also contribute to the increased propensity of cells for apoptosis. These results, in comparison with other published studies, suggest that the effects of the HCV core protein and their underlying mechanisms vary significantly among cells of different origins.
INTRODUCTION
Hepatitis C virus (HCV) is the major causative agent of non-A, non-B hepatitis (Alter et al., 1992; Choo et al., 1989) . The virus encodes three structural proteins (core, E1, and E2 proteins) and six nonstructural proteins from a 9.5-kb positive-sense, single-stranded RNA genome (Matsuura et al., 1994) . Among the structural proteins, the core protein not only constitutes the viral nucleocapsid, but also carries several presumptive regulatory functions. For example: It either enhances or suppresses various viral or cellular promoters (Ray et al., 1995; Shih et al., 1995) ; it binds to several putative transcription factors, including hnRNP K and RNA helicase, and potentially affects the expression of cellular genes (Hsieh et al., 1998; You et al., 1999b) ; and it has transforming activities (Ray et al., 1996 (Ray et al., , 2000 , but also activates or suppresses the p53 gene (Lu et al., 1999; Otsuka et al., 2000; Ray et al., 1997) . It also binds to at least two cytokine receptors, i.e., lymphotoxin ␤ receptor (Chen et al., 1997; Matsumoto et al., 1997) and tumor necrosis factor receptor-1 (TNFR1) (Zhu et al., 1998) . Correspondingly, the core protein may enhance the apoptosis induced by ligands of the TNF family, e.g., lymphotoxin ␣␤ complex, TNF, and Fas ligand (Chen et al., 1997; Ruggieri et al., 1997; Zhu et al., 1998) . However, the suppression of cytokine-induced apoptosis by the core protein has also been reported (Marusawa et al., 1999; Ray et al., 1998a) . The binding of the core protein to TNFR1 is particularly intriguing, because TNF is known to play an important role in liver pathology.
In our previous study, we showed that the core protein enhanced TNF-induced apoptosis in several mouse and human cell lines (Zhu et al., 1998) ; however, the mechanism of enhancement was not known. Crystallographic studies suggest that activation of TNFR1 occurs by ligand-mediated oligomerization through the death domain (DD) (Banner et al., 1993) . Extensive studies have shown that the DD is a protein-protein interacting domain, responsible for the recruitment of cellular signal transducers to the receptors during receptor engagement (Schulze-Osthoff et al., 1998) . The DD is also present in some of the TNFR-associated signal transduction molecules, such as TNFR-associated death domain protein (TRADD) and Fas-associated death domain protein (FADD) . Upon oligomerization of TNFR, TRADD is recruited, which subsequently recruits FADD, to the receptor. FADD (Boldin et al., 1995; Chin-naiyan et al., 1995) then directly interacts with the apoptotic proteases (Boldin et al., 1996; Muzio et al., 1996) and triggers apoptosis. However, recent studies suggested that TNFR may function as a preformed complex through a pre-ligand-binding assembly domain (Chan et al., 2000) , instead of the ligand-mediated oligomerization through the DD (Banner et al., 1993) . It is known that FADD activates caspases, such as CPP32, which are the ultimate executors of apoptosis (Fernandes-Alnemri and Alnemri, 1994; Nicholson et al., 1995; Tewari and Dixit, 1995) . On the other hand, the N-terminus of TRADD also recruits (TRAF2) TNFR-associated factor 2 through its TRAF domain , which then activates a c-jun N-terminal kinase (JNK) and nuclear factor-(NFB) (Yeh et al., 1997) . However, several different studies have suggested that NFB activation can also be mediated by pathways that are independent of TRAF2 (Shi and Kehrl, 1997) . Both JNK and NFB have been shown to be affected by the HCV core protein (Marusawa et al., 1999; Ray et al., 1998b; You et al., 1999a) ; however, in some cases, the activation status of these molecules did not correlate with the enhancement or suppression of the apoptosis of the cells.
In this study, using a human embryonic kidney 293 (HEK-293) cell line, which has a high transfection efficiency, we confirmed our previous finding (Zhu et al., 1998) that the core protein could sensitize cells to TNFinduced apoptosis. We showed that the core protein interacts not only with TNFR1 but also with the death domain of FADD, but not that of TRADD. The FADD pathway was further demonstrated to be the main pathway for the sensitization of the core protein-expressing cells to TNF. On the other hand, the core protein disrupted the recruitment of TRADD and TRAF2 to TNFR1. Correspondingly, TNF-induced activation of JNK was suppressed, which may also contribute to TNF sensitivity. However, TNF-induced NFB activation was not affected by the core protein, suggesting the presence of TRAF2-independent NFB activation. We conclude that HCV core protein sensitizes cells to TNF-induced apoptosis mainly by facilitating recruitment of FADD, which leads to apoptosis. Thus, the core protein has multiple effects on the signal transduction pathways of TNFR.
RESULTS

HCV core protein sensitizes HEK-293 cells to TNF-induced cell death
We previously demonstrated that the HCV core protein could sensitize three different cell lines, including murine BC10ME cells and human HeLa and HepG2 cells, to TNF-induced apoptosis in the presence of a transcription inhibitor actinomycin D (Zhu et al., 1998) . However, these cells have a low transfection efficiency and, thus, are not easily amenable to the studies of the signal transduction pathways of TNFR. Therefore, we attempted to establish core protein-expressing human embryonic kidney 293 cell lines, which are known to be efficient for transfection. HEK-293 cells were transfected with a plasmid encoding the full-length HCV core protein or the empty vector plasmid and selected with G418. Resistant cell colonies were pooled and designated 293/CORE and 293/EF, respectively. The cells were examined for core protein expression by immunoblotting. The core protein was detected in 293/CORE cells by immunoblotting, as shown in the inset of Fig. 1 . Furthermore, all cell lines express comparable levels of TNFR, as determined by Western blotting of the total cell lysates (data not shown). To test the sensitivity of these cells to TNF, cells were treated with human TNF-␣ in the presence of actinomycin D, and the percentage of cell death was determined by MTT assay. Similar to the core-expressing BC10ME, HeLa, and HepG2 cells (Zhu et al., 1998) , the core protein-expressing 293/CORE cells were more sensitive to TNF-induced apoptosis than the control 293/EF cells. The difference in TNF sensitivity between the two cell pools was approximately three-to fourfold in a wide range of TNF concentrations (Fig. 1 ).
HCV core protein interacts with FADD but not TRADD
To understand the mechanism of the core proteinenhanced sensitivity to TNF in 293 cells, we examined the status of various signal transduction pathways of TNFR in these cells. We have previously shown that the core protein binds to the death domain of the TNFR1 cytoplasmic region (Zhu et al., 1998) . To study how the core protein altered the signal transduction of TNFR1, we first looked at the possibility that the HCV core protein may also bind TRADD or FADD, both of which have a death domain and play critical roles in TNFR1-mediated apoptosis .
We used the glutathionine S-transferase (GST) pull-down assay to determine whether the core protein can interact directly with TRADD or FADD. Several GST-fusion proteins were tested for their ability to bind the 35 S-labeled, in vitro translated TRADD. As expected, TRADD binds to the cytoplasmic region of TNFR1 fused to GST, but not to GST alone. Furthermore, TRADD did not bind to the GST-CORE protein ( Fig. 2A) , indicating that there is no direct interaction between the core protein and TRADD. On the other hand, the in vitro translated, 35 S-labeled HCV core protein bound the GST-FADD fusion protein containing aa 80 to 205, which includes the death domain, but not the GST-CD40 fusion protein (Fig. 2B ). The core protein also did not bind GST alone. These results indicated that the HCV core protein interacts with FADD, but not with TRADD. The N-terminal hydrophilic portion (aa 1-153) of the core protein is sufficient for the binding to FADD (see below), similar to that required for the binding to TNFR (Zhu et al., 1998) . Therefore, the HCV core protein binds not only to TNFR1 as previously reported (Zhu et al., 1998) , but also to one of its signal transduction molecules, FADD. The binding of the core protein to TNFR1 was approximately threefold better than the binding between the core protein and FADD, based on the percentage of the 35 S-labeled core protein bound to the comparable amounts of the respective GST fusion proteins.
The HCV core protein interacts with FADD and potentiates FADD-induced apoptosis in 293 cells
To determine whether the core protein and FADD could interact with each other in the cells, we performed coimmunoprecipitation experiments. 293/EF and 293/ CORE cells were transfected with a plasmid expressing an N-terminal Flag-tagged FADD. Anti-Flag-conjugated beads were used to immunoprecipitate FADD, and the complex was separated by SDS-PAGE followed by immunoblotting for core protein. As shown in Fig. 3 , the core protein was coprecipitated with the overexpressed FADD from the core protein-expressing 293 cells (lane 3, Fig. 3 ). As a control, anti-Flag-conjugated beads did not precipitate the core protein in the absence of Flag-FADD (lane 1, Fig. 3 ). These results indicated that the HCV core protein could interact with FADD in 293 cells.
To test the possibility that the enhancement of sensitivity to TNF-induced apoptosis by the core protein is mediated through the FADD signaling pathway, we overexpressed TNFR1 and/or FADD in 293 cells in the presence or absence of the core protein. Consistent with the previous report , overexpression of either TNFR1 or FADD alone led to significant apoptosis in 293 cells stably transformed with either the core-expressing plasmid or the vector plasmid ( Fig. 4) . The core protein-expressing 293/CORE cells showed a slightly higher degree of apoptosis over the 293/EF cells, as determined by the number of dead cells (rounded and blebbing) and the number of remaining viable cells ( Fig.  4 , panels C and E versus panels D and F). The most significant difference between the two cell pools, however, was observed when the cells were cotransfected with both TNFR1 and FADD. In this case, the cells expressing the core protein (293/CORE) (panel H) had a significantly more pronounced apoptosis than the 293/EF cells (panel G). When a dominant-negative FADD (80-205) was cotransfected with TNFR1, the TNFR-induced apoptosis was reduced in both 293/EF and 293/CORE cells and there was no significant difference between the two cell pools. This result confirms the previous reports that TNFR1-mediated apoptosis is mediated primarily through FADD Hsu et al., 1996; Wajant et al., 1998; Wallach, 1997) . These results also FIG. 3 . In vivo interaction between HCV core protein and FADD. Approximately 5 ϫ 10 6 cells each of 293/EF (EF) or 293/CORE (CORE) were transfected with pKR-Flag-FADD. Cell lysates were incubated with 0.5 l of anti-Flag beads. After extensive washes, the captured proteins were resuspended in protein loading buffer and immunoblotted for core protein. Lysates without immunoprecipitation (Pre-IP) were included as positive controls. Lysates without transfection of pKR-Flag-FADD (lane 1) were included as negative controls.
FIG. 2.
In vitro GST binding assay of HCV core protein with TRADD and FADD. (A) 35 S-labeled in vitro translated TRADD (2 l) was incubated with 2 g of GST fusion proteins that express the cytoplasmic region of TNFR1, the entire core protein, or the GST protein alone. (B) 35 S-labeled in vitro translated core protein (2 l) was incubated with 2 g of GST fusion proteins that express the cytoplasmic region of CD40 or a truncated form of FADD (80-205). The bound proteins were separated by SDS-PAGE and detected by autoradiography.
showed that the core protein-induced sensitization of cells to TNFR1-mediated apoptosis could be blocked by the dominant-negative mutant of FADD. Therefore, the apoptosis-enhancing effect of the core protein was mediated mainly through the FADD pathway. These data established a direct role of the core protein in enhancing FADD-induced apoptosis in TNFR1 signaling.
We also examined the CPP32 caspase activity induced by TNF in the cells expressing the HCV core protein. The results showed that the CPP32 caspase activity was higher in the core-expressing cells than in the vectortransfected cells after TNF treatment (Fig. 5 ). This result is consistent with the finding that TNF induced a higher degree of apoptosis in the cells expressing the core protein.
In all of the experiments, the transfection efficiency was determined by cotransfection of a plasmid expressing the green fluorescent protein (GFP), which showed that an average of 80-90% of cells expressed GFP at 20 h posttransfection (data not shown). All these results support the hypothesis that HCV core protein enhanced TNF-induced apoptosis mainly by facilitating the recruitment and signaling of FADD.
HCV core protein disrupts the TNFR1-TRADD-TRAF2 complex
We next examined whether the core protein also affected other signaling pathways of TNFR, such as TRADD-TRAF2-mediated pathways. Since both core protein and TRADD bind to the death domain of TNFR1 (Tartaglia et al., 1993; Zhu et al., 1998) , and there is no direct in vitro interaction between the core protein and TRADD (Fig. 2) , it is conceivable that the binding of the core protein may disrupt TRADD signaling. Therefore, we examined whether the core protein would affect the potential formation of a TNFR1-TRADD-TRAF2 complex, which mediates TNFR signaling. To examine this possibility, constructs that express a GST protein fused to the TNFR1 cytoplasmic region with (GST/DD) or without (GST/NDD) the death domain were separately cotransfected with the plasmid expressing a truncated core protein (aa 1-153) into 293 cells. The truncated core protein was used in this study because its expression level was higher than that of the full-length core protein (data not shown). We have previously shown that the truncated core protein (aa 1-153) was sufficient for interaction with TNFR1 (Zhu et al., 1998) . Cytoplasmic extracts from the transfected cells were used for the GST pull-down assay and examined by immunoblotting for TRADD, TRAF2, the core protein, and GST fusion proteins. As shown in Fig. 6 , a GST fusion protein containing the death domain of TNFR1 was expressed in a much smaller amount than that lacking the death domain ( Fig.  6, lanes 1-4) ; nevertheless, both of them were pulled down efficiently by the glutathione beads (Fig. 6 , lanes 5-8). The core protein was detected in the GST pulldown fractions only in the cells expressing GST/DD but not GST/NDD (lanes 6 and 8), confirming the previous finding that the core protein binds to the death domain of TNFR1 (Zhu et al., 1998) . It is noteworthy that only a small fraction of the total core protein in the cells was pulled down by GST/DD, indicating that the core protein was much more abundantly expressed than GST/DD. In the absence of the core protein, the death domain, but not the non-death domain, of TNFR1 pulled down a significant amount of TRADD (Fig. 6, lanes 5 and 7) . This confirmed the previous report that TRADD interacted directly with TNFR1 in vivo . However, in the presence of the core protein, only a trace amount of TRADD was pulled down (lane 8), suggesting that the FIG. 5. CPP32 caspase assays. Approximately 2 ϫ 10 6 293 permanent cells were treated or untreated with human TNF (60 ng/ml) for 16 h in the presence of actinomycin D (1 g/ml). Equal amounts of cell lysates were subjected to CPP32 assay (Clontech) and the CPP32 activity was determined by reading at OD 400 . The data are the averages of two experiments. interaction between TRADD and TNFR1 was disrupted. As expected, TRAF2 was also pulled down by GST/DD, but not by GST/ NDD (lanes 5 and 7) , consistent with the report that, upon interaction with TNFR1, TRADD could recruit TRAF2 . In the presence of the core protein, TRAF2 was not precipitated by GST/DD (lane 8), suggesting that the disruption of the TRADD-TNFR1 interaction by the core protein also resulted in reduced recruitment of TRAF2. These results suggested that the core protein disrupted the formation of a TNFR1-TRADD-TRAF2 complex by competing with the binding of TRADD to the death domain of TNFR1.
HCV core protein disrupts TNF-induced JNK activation but not NFB activation TRAF2 has been suggested as the key mediator for NFB and JNK activation in TNF induction (Liu et al., 1996; Malinin et al., 1997) . The finding that the core protein disrupted the recruitment of TRAF2 in TNF induction led us to investigate whether NFB and JNK signaling were impaired in the presence of the core protein. NFB activation was assayed by the nuclear translocation of Rel A upon TNF stimulation. As we have shown in our previous work, the core protein suppressed NFB activation only in a mouse cell line (BC10ME), but not in two human cell lines tested (HeLa and HepG2). Results with 293 cells showed that the TNF treatment resulted in the nuclear translocation of roughly the same amount of Rel A in both the core protein-expressing cells (293/ CORE) and control (EF) cells (Fig. 7A ). This result suggests that the expression of the core protein did not result in significant suppression of NFB activation. In contrast, the activation of JNK (as assayed by the phosphorylation of c-jun) by TNF in the core-expressing cells was much weaker and had a slightly delayed kinetics compared to the control (EF) cells (Fig. 7B) . Quantitation of the phosphorylated c-jun indicated an approximately twofold reduction in the activation of JNK in the cells expressing the core protein. Western blotting of the JNK1 using anti-JNK1 antibody showed that the amounts of JNK1 proteins did not vary in any of the samples (Fig. 7B) . The inhibition of JNK activation may further contribute to the sensitivity of cells to TNF, although the role of JNK in TNF signaling may depend on cell conditions. There have been contradictory results regarding whether JNK activation is proapoptosis, antiapoptosis, or neither (Liu et al., 1996) (see Discussion) .
DISCUSSION
Previous studies from our laboratory have shown that expression of the HCV core protein in several human and mouse cell lines enhanced TNF-induced apoptosis, probably as a result of the binding of the core protein to TNFR1 (Zhu et al., 1998) . However, the mechanism of the enhanced TNF sensitivity was not previously known, and it may differ among different cell types. For example, TNF-induced NFB activation was suppressed in the core protein-expressing mouse cells (BC10ME) but not the human cells (HeLa and HepG2), although all three cell lines were similarly sensitized to TNF by the HCV core protein (Zhu et al., 1998) . By using a core proteinexpressing 293 cell system, which allows efficient trans- Approximately 1 ϫ 10 6 cells were treated with 10 ng/ml of TNF. Cell lysates were harvested at different time points and incubated with 0.3 g of goat anti-JNK1 antibody at 4°C for 2 h. Protein G-Sepharose (20 l) was added and incubated for an additional 1 h. The beads were washed and adjusted to 30 l in reaction buffer. The in vitro kinase assay was performed for 20 min at 30°C. The phosphorylation of c-jun was determined by SDS-PAGE followed by autoradiography (upper panel) and quantified using the Ambis PhosphorImaging System. The lower panel shows the immunoblotting using the JNK1specific antibody.
FIG. 6. The core protein disrupts the TNFR1-TRADD-TRAF2 complex in vivo. Approximately 5 ϫ 10 6 cells of 293/CORE or 293/EF cells infected with vTF-7 recombinant vaccinia virus (m.o.i., 1) for 2 h, followed by cotransfection with 5 g each of plasmids encoding the HCV core protein (aa 1-153) and GST/DD or GST/NDD of TNFR1 cytoplasmic regions. Cytoplasmic extract (60 g) from each sample was incubated with GST beads and the captured proteins were resolved by SDS-PAGE followed by immunoblots for GST fusion protein, HCV core protein, TRADD, and TRAF2. fection, we were able to elucidate in this study the signal transduction pathways that led to the enhanced TNF sensitivity. Two basic mechanisms account for this effect:
(1) Core protein binds to FADD and TNFR and thus recruits FADD to TNFR. The enhanced apoptosis mediated by the core protein was most evident when both TNFR and FADD were coexpressed, and this effect was almost completely blocked by a dominant-negative mutant of FADD. Therefore, FADD is probably the major mediator of the enhanced TNF sensitivity caused by the core protein.
(2) The TRADD-TRAF2 signal transduction pathway is blocked, probably because the core protein occupies the TRADD-binding site on the TNFR. As a result, JNK activation is suppressed, which may contribute to apoptosis, although the role of JNK in apoptosis has been controversial in the literature. In contrast to mouse cells, in which NFB activation was inhibited by the expression of the HCV core protein (Zhu et al., 1998) , the TNF-induced NFB activation was not inhibited by the core protein in 293 cells, suggesting that NFB can be activated by a TRAF2-independent pathway in human cells and that the core protein does not affect this pathway. These results combined thus explain the mechanism of the core protein-induced enhancement of TNF sensitivity in our cell lines.
The TRADD protein is like a two-edged sword, which leads to two opposing outcomes of TNFR1-mediated signaling. On the one hand, TRADD recruits FADD, which binds to caspase 8 and triggers a cascade of caspase activation, leading to apoptosis. On the other hand, TRADD also recruits TRAF2, which activates two distinct pathways. One involves the protein kinase NIK (Malinin et al., 1997) , which leads to NFB activation, while the other is independent of NIK (Natoli et al., 1997b) , which activates JNKs stress-activated protein kinases (SAPKs) (Liu et al., 1996) and, subsequently, several transcription factors, including c-jun (Reinhard et al., 1997) . It is known that NFB (Rel A) activation protects cells against apoptosis induced by TNF (Van Antwerp et al., 1996) . We did observe suppression by the core protein of Rel-A activation in a mouse cell line, but not in any of the human cell lines examined, including HepG2, HeLa, and 293 cells (Zhu et al., 1998) . This finding is not surprising, since TRAF2-independent NFB activation pathways do exist in the cells, as suggested by the lack of suppression of NFB activation in TRAF2 knockout mice (Yeh et al., 1997) . On the other hand, TRAF2 is the major mediator of JNK activation (Liu et al., 1996; Natoli et al., 1997a; Shi and Kehrl, 1997) . Consistently, we observed the suppression of JNK activation in the core protein-expressing cells. The role of JNK activation in TNFR signal transduction is still controversial; overexpression of TRAF2 does not stimulate apoptosis induced by TNF, and it is not required for TNF-induced apoptosis (Natoli et al., 1998) . However, it has been reported that the JNK pathway may protect cells against Fas-mediated apoptosis (Nishina et al., 1997) ; thus, the suppression of TRAF2 by the core protein may make cells proapoptotic. In summary, the recruitment of FADD to TNFR1 by the core protein appears to be the primary mechanism of the enhanced sensitivity to TNF by the HCV core protein. Nevertheless, the TRAF2-JNK pathway may also be involved.
Why then did different laboratories observe different effects of the HCV core protein on the cellular sensitivity to cytokines of the TNF family? We have consistently observed enhanced sensitivity to TNF in four different cell lines expressing the core protein, although the mechanism of enhancement varied from cell to cell. This enhanced sensitivity was also extended to other TNFrelated cytokines (lymphotoxin ␣␤ and Fas) in other cell lines (Chen et al., 1997; Ruggieri et al., 1997) . On the other hand, at least two laboratories observed a reduction of TNF sensitivity by the HCV core protein (Marusawa et al., 1999; Ray et al., 1998a) , and another cell line did not show altered sensitivity to TNF (You et al., 1999a) . Different cell lines also showed significantly different effects of the HCV core protein on signal transducers NFB and JNK, the intracellular levels of which did not correlate well with the extent of apoptosis. For example, the expression of HCV core protein in a breast cancer cell line, MCF7, which does not contain caspase 3 (Janicke et al., 1998) , rendered the cells more resistant to TNF-induced apoptosis (Ray et al., 1998a) , and yet NFB activation was suppressed and JNK was constitutively activated in these cells (Shrivastava et al., 1998) . These differences may be attributable to the differences in the viral core protein sequence used by different laboratories and in the cell culture conditions. Different HCV isolates showed significant sequence differences, and the core protein also is processed to different degrees in different cell lines (Hussy et al., 1996; Liu et al., 1996; Lo et al., 1994) . Furthermore, the HCV core protein can enhance or suppress the expression of certain cellular genes (Ray et al., 1995) and interact with hnRNP K (Hsieh et al., 1998) , RNA helicase (You et al., 1999b ), 14-3-3 protein (Aoki et al., 2000) , and bZIP protein (Jin et al., 2000) , all of which can conceivably modulate the effects of the core protein on the TNF response. The core protein also can constitutively induce apoptosis in the absence of TNF (Honda et al., 2000) . Therefore, the sensitization of cells to TNF-induced apoptosis by core protein is likely modulated by many factors, and not merely determined by the NFB or JNK levels. Thus far, we have shown that the core protein binds to the death domains of TNFR1 and FADD, but not of TRADD. Furthermore, TRADD binds both TNFR1 and FADD via the death domain interaction; however, TNFR1 does not interact with FADD directly , suggesting that there are differences among the various death domains. This selectivity potentially allows the core protein to enhance apoptosis through certain signaling pathways without affecting others. The relative abundance of the different signal transducers in different cells may contribute to the differences in the overall effects of the HCV core protein.
Although TNF plays a key role in the proliferative response in normal liver (Bradham et al., 1998; Diehl et al., 1994) , it has a direct cytotoxic role in injured or diseased liver. For example, in acute liver injury, TNF triggers apoptosis of hepatocytes and plays a central role in pathogenesis. In the endotoxin/galactosamine model, lipopolysaccharide induced a hepatocyte inflammatory response, resulting in an increase in TNF level, which preceded liver failure. Moreover, TNFR1 was indispensable for the induction of liver damage in this model Pfeffer et al., 1993) . TNF is also believed to contribute to liver cell damage in a concanavalin model . A direct cytotoxic role of TNF in human hepatocytes was established clinically during chemotherapy (Bradham et al., 1998) . TNF concentration was significantly higher in patients who did not survive an episode of acute alcoholic hepatitis (Bird et al., 1990) . Both hepatitis B and C viruses induce TNF expression in human liver and human hepatoma cell lines (Gonzalez-Amaro et al., 1994) . In summary, there is a consistent pattern of enhanced TNF signaling in injured or damaged liver, which is linked directly to hepatocytotoxicity. Sensitization of cells to TNF-induced apoptosis by HCV core protein thus has direct clinical relevance. In addition, an elevated TNF level in HCV-infected patients would make the core-expressing cells even more vulnerable. It is very likely that in the case of hepatitis C infection, HCV pathogenesis is a combined result of enhanced TNF signaling by HCV core protein and elevated TNF concentrations in patients.
MATERIALS AND METHODS
Cell lines
The 293 cell line, which was obtained from the American Tissue Culture Collection (ATCC), is a human embryonic kidney cell line transformed with adenovirus E1A protein. Cells were grown in Dulbecco's modified Eagle medium (DMEM; Irvine Scientific) supplemented with 10% fetal bovine serum (Gemini Bioproducts, Inc.). The 293 cells expressing the core protein were obtained by transfection with pcDEF/core (Zhu et al., 1998) , which expresses the full-length core protein of the HCV Taiwan strain (Chen et al., 1992) under the translation elongation factor-1 promoter (Kim et al., 1990) . Cells were selected in the presence of 0.6 mg/ml of G418 (Life Technologies) as described previously (Zhu et al., 1998) . The G418resistant cells were pooled and designated 293/CORE. As a control, cells transformed with the empty vector pcDEF were similarly obtained and named 293/EF.
Expression vectors
pEGFP-C1, which can express the green fluorescent protein in mammalian cells under the cytomegalovirus (CMV) promoter, was purchased from Clontech Laboratories, Inc. pcDNA/TNFR1 was constructed with the entire TNFR1 gene being inserted in the BamH1 and EcoR1 sites of the pcDNA3 vector (Clontech) under the CMV promoter. pRK-Flag-mFADD and pRK-myc-TRADD, which express Flag-tagged FADD and myc-tagged TRADD proteins, respectively, were kindly provided by Dr. D. Goeddel . FADD (80-205), a deletion mutant of FADD containing amino acids 80-205, was made by PCR and cloned into the BamHI and EcoRI sites of pcDNA3 under T7 and CMV promoters. GST/DD was constructed with glutathione S-transferase fused to the fragment of TNFR1 that contains the death domain (aa 340-426) and inserted into pBluescript vector (Pharmacia) at the BamHI site. GST/NDD was constructed similarly by inserting GST fused to the non-death domain cytoplasmic tail of TNFR (aa 205-308) into pBlueScript at the BamHI site. The resulting plasmids GST/DD and GST/NDD can express the respective GST fusion proteins under the T7 promoter in mammalian cells when coinfected with the recombinant vaccinia virus vT-7 that expresses the T7 RNA polymerase (Frederick et al., 1987) .
MTT assay
Approximately 4 ϫ 10 4 cells were treated with human TNF (R&D, Inc.) at various concentrations in the presence of 1 g actinomycin D per milliliter for 16 h and stained by 1 mg of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Research Organics, Inc.) for 3 h as described previously (Zhu et al., 1998) . The percentage of cell death was calculated based on the OD 560 according to the following formula: percentage of cell death ϭ 100 Ϫ OD 560 of TNF-treated sample/OD 560 of untreated sample). All experiments were performed in triplicates in 96-well plates. The standard deviation was calculated from data of three independently performed experiments.
In vitro GST-binding assay GST fusion proteins were expressed in Escherichia coli BL21(DE) (Novagen) and purified with glutathione-Sepharose 4B beads as specified by the manufacturer (Pharmacia Biotech). GST-TNFR1 and GST-CD40 were GST fusion proteins that contained the entire cytoplasmic region of the corresponding receptors (Zhu et al., 1998) . GST-CORE was a GST fusion protein that expressed the entire HCV core protein. GST-FADD was a GST fusion protein that expressed amino acids 80-205 of FADD, which lacks the ligand-binding domain . 35 S-labeled in vitro translated protein (2 l) was incubated with approximately 2 g of GST fusion proteins attached to Sepharose beads at 4°C for 2 h in binding buffer [40 mM HEPES (pH 7.5), 100 mM KCl, 0.1% Nonidet P-40, 20 mM 2-mercaptoethanol)]. The beads were subsequently washed four times and were ana-lyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by autoradiography.
Coimmunoprecipitation and in vivo GST-binding assay
Cytoplasmic extracts were prepared as previously reported (Zhu et al., 1998) . Briefly, cell pellets were resuspended in 100 l buffer A [10 mM HEPES-KOH (pH 7.8), 10 mM KCl, 1.5 mM MgCl 2 , 20% glycerol, 0.5 mM dithiothreitol) and incubated on ice for 15 min. The lysate was brought to 0.5% of Nonidet P-40 before centrifugation at 8000 rpm for 5 min at 4°C in a microfuge. The supernatant (cytoplasmic extract) was collected, and protein concentration was measured by Bio-Rad protein assay.
For in vivo coimmunoprecipitation assays, approximately 5 ϫ 10 6 cells of 293/EF or 293/CORE cells were transfected with 5 g of pRK-Flag-FADD by the DOTAP method (Boehringer Mannheim). Cytoplasmic extract was prepared 48 h after transfection. A quantity of 0.5 l of Flag beads (VWR Scientific Products) was incubated with 40 l of cytoplasmic extract in a total volume of 400 l reaction buffer [40 mM HEPES (pH 7.5), 100 mM KCl, 0.5% Nonidet P-40, 20 mM 2-mercaptoethanol). After five washings with the reaction buffer, the Flag beads were resuspended in protein loading buffer and analyzed by immunoblot with anti-core protein antibody.
Approximately 5 ϫ 10 6 permanent 293 cells were infected with vT-7 vaccinia virus (Fuerst et al., 1986 ) (m.o.i. ϭ 1) for 2 h, followed by transfection with 5 g of plasmids encoding the HCV core protein (aa 1-153) and those encoding GST/DD or GST/NDD of the TNFR1 cytoplasmic regions, all of which are under the T7 promoter. The cytoplasmic extract was prepared 14 h after transfection. Total protein (60 g) for each sample was loaded on 12.5% SDS-PAGE. Immunoblots were performed using rabbit anti-core protein antibody, rabbit anti-GST antibody (Santa Cruz Biotechnology, Inc.), goat anti-TRADD antibody (Santa Cruz Biotechnology, Inc.), or rabbit anti-TRAF2 antibody (Santa Cruz Biotechnology, Inc.).
Overexpression of TNFR1 and FADD
Approximately 5 ϫ 10 5 permanent 293/EF and 293/ CORE cells were transfected with combinations of 1.5 g of pcDNA/TNFR1 or pRK-Flag-FADD or FADD (80-205). pEGFP-C1 (0.2 g) was cotransfected as an indicator of transfection efficiency, which was determined at 20 h posttransfection. The vector plasmid pcDNA3 was used to adjust all transfections to the same amount of total DNA. Cells were examined by light microscopy at 40 h posttransfection.
CPP32 caspase assay
Approximately 2 ϫ 10 6 293 permanent cells were treated with human TNF (60 ng/ml) for 16 h in the presence of actinomycin D (1 g/ml). Cells were washed and lysed according to the manufacturer's instructions (ApoAlert, CPP32/Caspase-3 assay kits, Clontech Laboratories, Inc.). Cell lysates were normalized with Bio-Rad protein assay first before they were subjected to CPP32 assay. The CPP32 activity was proportionally reflected by the optical density at a wavelength of 400 nm.
JNK kinase assay
Approximately 10 6 cells were treated with 10 ng/ml of TNF for 5 to 30 min. Cells were then lysed with 400 l of Triton lysis buffer [20 mM Tris-HCl (pH 7.5), 137 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 5 mM EDTA, 2 mM EGTA, 1 mM Na 3 VO 4 , 25 mM ␤-glycerophosphate, 50 mM NaF, 10 mM sodium pyrophosphate, 15% (v/v) glycerol, and 1% (v/v) Triton X-100] (Yeh et al., 1997) . Cell lysates were centrifuged and the supernatant was incubated with 0.3 g of goat anti-JNK1 antibody (Santa Cruz Biotechnology, Inc.) at 4°C for 2 h. Protein G-Sepharose (20 ml) was added and incubated for an additional 1 h. The beads were washed twice with Triton lysis buffer and twice with JNK reaction buffer [25 mM HEPES (pH 7.4), 25 mM ␤-glycerophosphate, 25 mM MgCl 2 , 2 mM dithiothreitol (DTT), and 0.1 mM Na 3 VO 4 ). The final volume of the beads was adjusted to 30 l in reaction buffer. A quantity of 1 g of GST-c-jun (aa 1-79) (Santa Cruz Biotechnology, Inc.), 6 l of 100 mM ATP, 1 l of 0.5 Ci[␥ 32 P]ATP, and 15 l of the beads in a total volume of 30 l of reaction buffer were incubated for 20 min at 30°C. The reactions were stopped by addition of 2ϫ loading buffer. The kinase activity was determined by SDS-PAGE followed by autoradiography. The amount of phosphorylated c-jun was used as the measurement of JNK activity.
NFB nuclear translocation
Cytoplasmic extract was prepared as described above. The pellet from centrifugation was resuspended in buffer C [20 mM HEPES-KOH (pH 7.8), 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% glycerol, 0.5 mM DTT] and incubated at 4°C for 30 min. The mixture was spun at the maximum speed for 10 min at 4°C in a microfuge, and the supernatant was collected as the nuclear extract. The protein concentration of the extract was determined by Bio-Rad protein assay. Approximately 60 g of total protein from each extraction was separated by SDS-PAGE and subjected to immunoblotting with goat anti-Rel A antibody (Santa Cruz Biotechnology, Inc.).
